Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
CESC | rs12680498 | chr8:144406881 | G/A | 6.13E-5 | 292 | 27.2 | 21.1 | 18 | KM Plot |
CESC | rs12706538 | chr7:123211572 | T/C | 3.78E-6 | 293 | 24 | 18.17 | 3.72 | KM Plot |
CESC | rs12741924 | chr1:112298875 | G/C | 0 | 296 | 21.33 | 20.47 | 4.07 | KM Plot |
CESC | rs12806061 | chr11:3008404 | G/A | 5.32E-5 | 295 | 21.4 | 21.1 | 21.73 | KM Plot |
CESC | rs12861519 | chr13:100029555 | A/C | 1.18E-5 | 292 | 23.92 | 21.2 | 14.8 | KM Plot |
CESC | rs1288351 | chr1:53624338 | A/G | 7.51E-6 | 299 | 1.53 | 20.03 | 22.88 | KM Plot |
CESC | rs12927044 | chr16:71930105 | C/A | 2.87E-6 | 288 | 23.83 | 18.45 | 5.53 | KM Plot |
CESC | rs13003061 | chr2:3482722 | C/T | 2.42E-8 | 297 | 21.07 | 27.9 | 1.43 | KM Plot |
CESC | rs13006095 | chr2:3486352 | G/A | 4.01E-8 | 289 | 20.92 | 29.27 | 1.43 | KM Plot |
CESC | rs13023769 | chr2:3491430 | C/T | 2.31E-8 | 293 | 20.92 | 31.22 | 1.43 | KM Plot |
CESC | rs13038092 | chr20:25249734 | C/T | 0 | 299 | 2.47 | 21.2 | 21.27 | KM Plot |
CESC | rs13059340 | chr3:161062631 | T/C | 3.6E-5 | 296 | 24.9 | 20.13 | 19.73 | KM Plot |
CESC | rs13062740 | chr3:161024208 | G/A | 1.48E-5 | 296 | 25.27 | 19.53 | 19.4 | KM Plot |
CESC | rs13073147 | chr3:161045237 | T/C | 9.95E-6 | 297 | 26.27 | 20.38 | 19.05 | KM Plot |
CESC | rs13074029 | chr3:99881567 | C/T | 3.39E-5 | 293 | 21.2 | 20.15 | 10.17 | KM Plot |